These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37568795)

  • 1. Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy.
    Le Reun E; Granzotto A; Pêtre A; Bodgi L; Beldjoudi G; Lacornerie T; Vallet V; Bouchet A; Al-Choboq J; Bourguignon M; Thariat J; Bourhis J; Lartigau E; Foray N
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
    Royce TJ; Mavroidis P; Wang K; Falchook AD; Sheets NC; Fuller DB; Collins SP; El Naqa I; Song DY; Ding GX; Nahum AE; Jackson A; Grimm J; Yorke E; Chen RC
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):227-236. PubMed ID: 32900561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
    Kole TP; Nichols RC; Lei S; Wu B; Huh SN; Morris CG; Lee S; Tong M; Mendenhall NP; Dritschilo A; Collins SP
    Acta Oncol; 2015 Jun; 54(6):825-31. PubMed ID: 25227898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Very low-dose hyper-radiosensitivity: impact for radiotherapy of micrometastases].
    Thomas C; Fertil B; Foray N
    Cancer Radiother; 2007 Sep; 11(5):260-5. PubMed ID: 17683966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
    Stinauer MA; Kavanagh BD; Schefter TE; Gonzalez R; Flaig T; Lewis K; Robinson W; Chidel M; Glode M; Raben D
    Radiat Oncol; 2011 Apr; 6():34. PubMed ID: 21477295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Mahadevan A; Moningi S; Grimm J; Li XA; Forster KM; Palta M; Prior P; Goodman KA; Narang A; Heron DE; Lo SS; Urbanic J; Herman JM
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):206-216. PubMed ID: 33358561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The radiobiological targets of SBRT: tumor cells or endothelial cells?
    Karam SD; Bhatia S
    Ann Transl Med; 2015 Nov; 3(19):290. PubMed ID: 26697450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma.
    Verduijn GM; Petit SF; Lauwers I; van Norden Y; Sijtsema ND; Sewnaik A; Mast H; Capala M; Nout R; Baker S; van Meerten E; Hoogeman MS; van der Lugt A; Heemsbergen WD
    Acta Oncol; 2023 Jan; 62(1):40-47. PubMed ID: 36576773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
    Brown JM; Carlson DJ; Brenner DJ
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):254-62. PubMed ID: 24411596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopotentiating effects of low-dose fractionated radiation on cisplatin and paclitaxel in cervix cancer cell lines and normal fibroblasts from patients with cervix cancer.
    Słonina D; Kabat D; Biesaga B; Janecka-Widła A; Szatkowski W
    DNA Repair (Amst); 2021 Jul; 103():103113. PubMed ID: 33839463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forcing lateral electron disequilibrium to spare lung tissue: a novel technique for stereotactic body radiation therapy of lung cancer.
    Disher B; Hajdok G; Gaede S; Mulligan M; Battista JJ
    Phys Med Biol; 2013 Oct; 58(19):6641-62. PubMed ID: 24018569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.
    Prasanna A; Ahmed MM; Mohiuddin M; Coleman CN
    J Thorac Dis; 2014 Apr; 6(4):287-302. PubMed ID: 24688774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
    Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
    Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
    Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
    Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
    Sahgal A; Chang JH; Ma L; Marks LB; Milano MT; Medin P; Niemierko A; Soltys SG; Tomé WA; Wong CS; Yorke E; Grimm J; Jackson A
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):124-136. PubMed ID: 31606528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.
    Oermann EK; Slack RS; Hanscom HN; Lei S; Suy S; Park HU; Kim JS; Sherer BA; Collins BT; Satinsky AN; Harter KW; Batipps GP; Constantinople NL; Dejter SW; Maxted WC; Regan JB; Pahira JJ; McGeagh KG; Jha RC; Dawson NA; Dritschilo A; Lynch JH; Collins SP
    Technol Cancer Res Treat; 2010 Oct; 9(5):453-62. PubMed ID: 20815416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.